The US biopharma will discontinue development of the Exondys 51 (eteplirsen) follow up treatment to focus on other treatment ...

Discover 10 travel experiences, from exotic expeditions to wellness retreats, offering adventures and cultural immersion for the ultimate gift for travelers.

Mitochondria In Motion Inc. has identified new N-(trans-4-hydroxycyclohexyl)-6-phenylhexanamide derivatives acting as mitofusin activators and reported to be useful for the treatment of Alzheimer’s, ...

Sara McCready launched Gnome and Away Travel in February with her husband Kevin. Becoming a Hays Travel Explorer franchisee ...

Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions.

Alan Jackson's next farewell tour concert is on Saturday, Nov. 16, 2024, in Salt Lake City, Utah. In this file photo, he ...